Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan Hydrochloride”

1,153 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,153 results

Testing effectiveness (Phase 2)Study completedNCT00827684
What this trial is testing

Temsirolimus and Irinotecan for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations

Who this might be right for
Metastatic Colorectal Cancer
Vejle Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05969899
What this trial is testing

Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fudan University 50
Testing effectiveness (Phase 2)Study completedNCT00020917
What this trial is testing

Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00016250
What this trial is testing

Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Post-approval studies (Phase 4)Study completedNCT00138060
What this trial is testing

Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherche Clinique sur les Cancers et le Sang 71
Early research (Phase 1)WithdrawnNCT02573220
What this trial is testing

Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer

Who this might be right for
Stage IVA Colorectal CancerStage IVB Colorectal Cancer
University of Chicago
Testing effectiveness (Phase 2)Looking for participantsNCT04267978
What this trial is testing

Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas

Who this might be right for
Glioblastoma, RecurrentLower Grade Glioma, Recurrent
Beijing Sanbo Brain Hospital 109
Testing effectiveness (Phase 2)UnknownNCT00006115
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Study completedNCT00004078
What this trial is testing

Irinotecan in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+18 more
Children's Oncology Group 181
Large-scale testing (Phase 3)Looking for participantsNCT04342910
What this trial is testing

Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC

Who this might be right for
Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd. 550
Testing effectiveness (Phase 2)Study completedNCT01905150
What this trial is testing

Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Bruckner Oncology 34
Early research (Phase 1)Study completedNCT01274624
What this trial is testing

Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer

Who this might be right for
KRAS Mutant Metastatic Colorectal Cancer
Oncolytics Biotech 36
Testing effectiveness (Phase 2)Ended earlyNCT00717990
What this trial is testing

Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment

Who this might be right for
Metastatic Colorectal Cancer
University Hospital of Crete 15
Testing effectiveness (Phase 2)UnknownNCT02071069
What this trial is testing

Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer

Who this might be right for
Incurable Colorectal CancerRAS-wild-type
Tianshu Liu 54
Early research (Phase 1)Ended earlyNCT00403052
What this trial is testing

1018 Immunostimulatory Sequence (ISS) Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Dynavax Technologies Corporation 14
Testing effectiveness (Phase 2)Study completedNCT01075048
What this trial is testing

ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Daiichi Sankyo 131
Early research (Phase 1)WithdrawnNCT03380689
What this trial is testing

Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fujian Cancer Hospital
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06172036
What this trial is testing

Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab

Who this might be right for
Neoadjuvant ChemotherapyResectable Pancreatic Cancer
Zhejiang University 180
Testing effectiveness (Phase 2)Study completedNCT03778593
What this trial is testing

FOLFIRINOX for 2nd-line Treatment of BTC

Who this might be right for
Biliary Tract Cancer
Dong-A University Hospital 34
Testing effectiveness (Phase 2)UnknownNCT00839111
What this trial is testing

Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment

Who this might be right for
Colorectal Neoplasms
Fudan University 43
Load More Results